Tg Therapeutics (TGTX) EBT Margin Growth (3y) (2020 - 2026)
Tg Therapeutics (TGTX) EBT Margin Growth (3y) (2020 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBT Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
49,756.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
441.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Tg Therapeutics |
7.71 Bn |
7.06 Bn |
171.41 Mn |
51,272.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
51,272.00 |
| Dec 31, 2025 |
10.05 Mn |
| Sep 30, 2025 |
3.90 Mn |
| Jun 30, 2025 |
708,554.00 |
| Mar 31, 2025 |
345,373.00 |
| Dec 31, 2024 |
407,544.00 |
| Sep 30, 2024 |
424,972.00 |
| Jun 30, 2024 |
512,963.00 |
| Mar 31, 2024 |
1.15 Mn |
| Dec 31, 2023 |
23.17 Mn |
| Sep 30, 2023 |
22.99 Mn |
| Jun 30, 2023 |
13.94 Mn |
| Mar 31, 2023 |
13.49 Mn |
| Dec 31, 2022 |
439,349.00 |
| Sep 30, 2022 |
12.53 Mn |
| Jun 30, 2022 |
8.65 Mn |
| Mar 31, 2022 |
8.95 Mn |
| Dec 31, 2021 |
13.83 Mn |
| Sep 30, 2021 |
8.60 Mn |
| Jun 30, 2021 |
-12.24 Mn |
